Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.
AGOURA HILLS, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
AGOURA HILLS, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
DUBAI, United Arab Emirates, Nov. 23, 2023 (GLOBE NEWSWIRE) — TPAY, the leader in payments…
FOSTER CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (the “Company”),…
Customers used 79.3 TB of data over Verizon’s fast, reliable 5G Ultra Wideband network. Network…
LAS VEGAS, Nov. 21, 2023 (GLOBE NEWSWIRE) — Verizon and Open Sesame Media are working…
Expands MedAvail’s presence among Federally Qualified Health Centers (FQHCs) PHOENIX, Nov. 28, 2023 (GLOBE NEWSWIRE)…
CHATHAM, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
VANCOUVER, British Columbia, Nov. 20, 2023 (GLOBE NEWSWIRE) — Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW)…
BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Helping Military Base with IoT Modernization Efforts FREMONT, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) —…
Helping Military Base with IoT Modernization Efforts FREMONT, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) —…
TTC Rogers Coverage EN_HighRes TTC Rogers Coverage EN_HighRes Introduces Rogers 5G to tunnels in the…
WATERTOWN, Mass., Nov. 28, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a…
TTC Rogers Coverage EN_HighRes TTC Rogers Coverage EN_HighRes Introduces Rogers 5G to tunnels in the…
What you need to know: The agreement between Norfolk International Terminal (NIT) and Verizon Business…
What you need to know: The agreement between Norfolk International Terminal (NIT) and Verizon Business…
SBI-100 Ophthalmic Emulsion, a CB1 agonist/activator delivered as a topical eye drop, was developed to…
LISBON, Portugal, Nov. 14, 2023 (GLOBE NEWSWIRE) — In response to a surge in demand…
LISBON, Portugal, Nov. 14, 2023 (GLOBE NEWSWIRE) — In response to a surge in demand…
Dr. Kobayashi brings over 25 years of experience in oncology drug development, including Antibody Drug…